SMP-3124LP in Adults With Advanced Solid Tumors
Recruiting · Phase 1, Phase 2 · NCT06526819
Conditions: Solid Tumor
At a glance
- Research payments reported, 2025
- $448,805
- U.S. investigators named
- 7
- Sites paid
- 9
- Planned or actual enrollment
- 120
About the trial
- Sponsor
- Sumitomo Pharma America, Inc.
- Tested
- SMP3124LP (drug)
- Dates
- Started 2024-08-14; completion 2029-05
- Results posted
- Not yet
An Open-label, Phase I Dose Escalation and Phase 2 Dose Expansion Study to Assess Safety, Tolerability, Preliminary Antitumor Activity of SMP 3124LP in Adults with Advanced Solid Tumors
From ClinicalTrials.gov, last updated 2026-10-15. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Sumitomo Pharma America, Inc. reported $448,805 in research payments for this study in 2025 (388 payments).
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Navid Hafez, M.D. Hematology & Oncology · Los Angeles, CA
- Vivek Subbiah, MD Medical Oncology · Stanford, CA
- Gerald S. Falchook, MD Medical Oncology · Denver, CO
- Young Kwang Chae, MD, MPH, MBA Hematology & Oncology · Chicago, IL
- Margaret E. Gatti-mays, M.D. Medical Oncology · Columbus, OH
- Cathy Eng, M.D. Medical Oncology · Nashville, TN
- Timothy A. Yap, MD Medical Oncology · Houston, TX
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Sarah Cannon Research Institute LLC $157,382
- Vanderbilt University Medical Center, TN $127,137
- Ut MD Anderson Cancer Center $94,932
- Cedars-Sinai Medical Center, CA $50,216
- Sarah Cannon Research Institute at Healthone $9,071
- Sarah Cannon Research Institute Op $3,096
- Ohio State University Medical Center $2,465
- Stefanie Spielman Comprehensive Breast Cntr $2,309
- Northwestern University $2,197
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.